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Abstract
Escherichia coli strains causing urinary tract infection (UTI) are increasingly recognized as belonging to specific clones. E. coli
clone O25b:H4-ST131 has recently emerged globally as a leading multi-drug resistant pathogen causing urinary tract and
bloodstream infections in hospitals and the community. While most molecular studies to date examine the mechanisms
conferring multi-drug resistance in E. coli ST131, relatively little is known about their virulence potential. Here we examined
E. coli ST131 clinical isolates from two geographically diverse collections, one representing the major pathogenic lineages
causing UTI across the United Kingdom and a second representing UTI isolates from patients presenting at two large
hospitals in Australia. We determined a draft genome sequence for one representative isolate, E. coli EC958, which produced
CTX-M-15 extended-spectrum b-lactamase, CMY-23 type AmpC cephalosporinase and was resistant to ciprofloxacin.
Comparative genome analysis indicated that EC958 encodes virulence genes commonly associated with uropathogenic E.
coli (UPEC). The genome sequence of EC958 revealed a transposon insertion in the fimB gene encoding the activator of type
1 fimbriae, an important UPEC bladder colonization factor. We identified the same fimB transposon insertion in 59% of the
ST131 UK isolates, as well as 71% of ST131 isolates from Australia, suggesting this mutation is common among E. coli ST131
strains. Insertional inactivation of fimB resulted in a phenotype resembling a slower off-to-on switching for type 1 fimbriae.
Type 1 fimbriae expression could still be induced in fimB-null isolates; this correlated strongly with adherence to and
invasion of human bladder cells and bladder colonisation in a mouse UTI model. We conclude that E. coli ST131 is a
geographically widespread, antibiotic resistant clone that has the capacity to produce numerous virulence factors
associated with UTI.
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Introduction
Clonal dissemination of uropathogenic Escherichia coli (UPEC)
occurs much more often than is commonly realized [1]. For
example, a decade ago, trimethoprim/sulfamethoxazole (TMP/
SMX) resistant E. coli ‘‘clonal group A’’ was found to be
widespread across the United States [2]. Within the last five
years, E. coli clone O25:H4-ST131 (E. coli ST131) has emerged as
an important multi-drug resistant extraintestinal pathogen world-
wide. Several epidemiological studies have shown E. coli ST131 to
be a major cause of urinary tract and bloodstream infections
within the community as well as in hospitals and long-term care
facilities in Europe, Asia, Africa, North America and Australia
[3,4,5,6,7,8]. In addition, E. coli ST131 are also major contributors
to what is known as ‘the CTX-M pandemic’; a recent worldwide
increase in E. coli uropathogens that produce CTX-M type type
(‘active on CefoTaXime, first isolated in Munich’) extended
spectrum b-lactamases (ESBLs) [9]. E. coli ST131 are commonly
identified among E. coli producing CTX-M-15; currently the most
widespread CTX-M ESBL enzyme worldwide [7,10]. ESBLs
mediate resistance to oxyimino-cephalosporins and monobactams
but not the cephamycins. Additionally, E. coli ST131 is frequently
resistant to fluoroquinolones [6,11]. Therefore, this clone is
typically associated with limited treatment options.
Clinical evidence also suggests that pathogens within the ST131
group are highly virulent. Two clinical studies have reported
transmission of E. coli ST131 strains causing pyelonephritis and
septic shock between family members [12,13]. In addition,
phylogenetic analyses of large isolate collections from different
geographical locations assign the majority of ST131 strains to
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phylogenetic group B2, which predominantly comprises virulent
extraintestinal E. coli strains. Despite this, PCR studies that
screened ST131 strains for the presence of several established
virulence genes reported the absence of traits commonly associated
with B2 phylogeny, particularly adhesins (e.g. P, S and F1C
fimbriae) and toxins (e.g. alpha-hemolysin and cytotoxic necrotiz-
ing factor 1). In fact only a few virulence genes appear to be
uniformly present in strains of the ST131 clone, such as the fimH
adhesin of type 1 fimbriae, the secreted autotransporter toxin (sat),
the aerobactin receptor (iutA), the uropathogenic-specific protein
(usp), and the pathogenicity island marker (malX) [6,7,11,14]. Thus,
our understanding of the virulence capacity of E. coli ST131
remains limited, particularly at the level of functional character-
isation of virulence determinants. Here we describe the genome
sequence of E. coli EC958, a multi-drug resistant, phylogenetic
group B2, ST131 serotype O25b:H4 strain isolated from the
Northwest region of England and use this information to identify
and characterise a novel mutation that affects the expression of
type 1 fimbriae, a major UPEC virulence factor.
Results and Discussion
Genome sequence of E. coli strain EC958, a clinical isolate
representing ST131 E. coli pathogens from the UK
Fifty four E. coli isolates belonging to the ST131 MLST group
were collected from patients presenting to both general practice
and hospitals in the Northwest region of England, from an area
encompassing Greater Manchester in the South to the Lake
District in the North (,150 km South to North). Isolates were
recovered during the period of October 2004–June 2009. ST131
strains represent the major pathogenic lineages (PFGE strains A-E)
causing UTI across the UK [15]. Strain EC958 was selected as a
representative of the ST131 CTX-M-15 producing lineage
circulating in the region as it was recovered from a urine sample
of a patient presenting in the community with UTI, was
gentamicin susceptible, resistant to ciprofloxacin (both character-
istic features of ST131 isolates in our collections), produced CTX-
M-15 ESBL and carried the CMY-23 type AmpC cephalospor-
inase [16]. In addition, EC958 is a member of the PFGE defined
UK epidemic strain A [15]. A draft genome sequence of EC958
was determined to approximately 29 times coverage. The
chromosome was assembled into 14 linear scaffolds with an
estimated length of 5,070,614 bp (Figure 1) with two additional
circular scaffolds of 133,977 bp and 4088 bp representing a large
low-copy and a small high-copy plasmid, respectively. The small
plasmid is 97% identical to the 4082 bp pSE11-6 plasmid
(dbj|AP009246) identified in the commensal E. coli strain SE11.
A comparison with complete E. coli genomes indicated that EC958
contains several regions of difference (RODs) (Figure 1). These
regions are mostly identifiable as prophage elements, with at least
7 distinct loci identified (Figure 1). There are also several loci
present in EC958 that are known to be variable across E. coli
including the Flag-2 lateral flagellar locus, the O-antigen loci, the
ratA-like toxin encoding gene, the type VI secretion locus and the
capsular locus. Comparisons with other UPEC strains (CFT073
[17], 536 [18], UTI89 [19], UMN026 and IAI39 [20]) indicate
the presence of four genomic islands in chromosomal integration
hot-spots (GI-pheV, GI-selC, GI-leuX and GI-thrW, Figure 1). Like
the equivalent islands in other UPEC strains, these islands share a
modular structure with different combinations and arrangement of
virulence-associated genes separated by IS elements [20]. EC958
also carries a 31,448 bp tRNA-asnT associated island that shares
99% identity to the High Pathogenicity Island from Yersinia pestis
[21]. Finally, there are 3 RODs with a length greater than 10 kb
with no similarity to known UPEC genomic islands (ROD1–3,
Figure 1).
Antibiotic resistance genes encoded in the pEC958
plasmid
The EC958 genome assembly includes a large plasmid
(,134 kb) with high identity to two previously described ST131
plasmids, pEK499 (from a UK strain A isolate) and pC15-1a,
[22,23]. Plasmid pEC958 is assembled in a single circular scaffold
and shares 99–100% identity across 92% of pEK499, including all
of the resistance genes found on pEK499 (Table 1). Like other
ST131 antibiotic resistance plasmids, antibiotic resistance genes
are clustered in cassettes between IS elements (particularly IS26),
contributing to reassortment and inversions within this region
(Table 1). The conjugal transfer region of pEC958 appears to be a
composite of pEK499 and pC15-1a. Plasmid pEC958 shares high
identity to the pEK499 tra region (including the same traJ allele)
and almost complete synteny in the ,36 kb between the rep and
traC genes. In contrast to pEK499, pEC958 contains a 22 kb
region encoding traNFQHGSTDIX conjugal transfer genes that are
missing from pEK499 but present in pC15-1a (encompassing the
region between ygeA and finO in pEC958). Notably, pEC958 lacks
a small region of tra genes (trbI, traW and traU) suggesting that its
conjugation apparatus may not be functional, as suggested for
pEK499 [22].
Virulence factors of EC958
The genome of EC958 contains genes encoding for a variety of
potential virulence factors including numerous adhesins, auto-
transporters, and siderophore receptors (Table 2). These genes
correlate well with those reported in recent PCR based studies
from the USA [11] and Spain [14], though the current work
demonstrates a number of additional virulence genes are present
in ST131. In other UPEC strains, several of the virulence factors
present in EC958 are found in integrative genomic islands in
known chromosomal integration hot-spots. Most important of
these appears to be GI-pheV, which in EC958 is similar in content
and arrangement to the 39 modules of CFT073 pathogenicity
island II including genes for the secreted autotransporter toxin sat,
an agn43 homolog and the siderophore receptors iutA and iha
(Table 2). In contrast to the canonical CFT073 pheV island, EC958
GI-pheV lacks the region between the int and papI genes and
exhibits a translocation and inversion of the sat/iutA modules [17].
The 51.3 kb GI-selC in EC958 shares the same 59 region with
CFT073 GI-selC, but is otherwise distinct from other UPEC
islands. It carries a complete Dr/Afa chaperone-usher fimbrial
operon, which may be important for colonization of the urinary
tract. In EC958, the 79.1 kb GI-leuX carries the ,10 kb fec
siderophore receptor locus found in both UMN026 and IAI39
tRNA-leuX islands, but the remaining sequence has not been
previously observed in sequenced UPEC strains. At the tRNA-
thrW chromosomal integration hot-spot, EC958 contains a 10.8 kb
genomic island encoding a type I restriction/modification system
near-identical to the equivalent region in the B2 commensal E. coli
O150:H5 strain SE15 [24] but distinct to that in other published
UPEC genomes.
In addition, EC958 contains three large regions of difference
(RODs 1–3, Figure 1). Interestingly, all share very high identity
with syntenic regions in E. coli SE15. Both ROD1 and ROD2
contain integrase genes; while ROD2 also contains genes with a
predicted sugar transport/metabolism function, the general
function of ROD1 genes is unclear. ROD3 carries two tandemly
arranged autotransporter homologs (one with 87% nucleotide
identity to the 1.2 kb 39 region of picU), a chaperone-usher gene
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pair and putative fimbrial subunit gene. Given their presence in
SE15, these regions may contribute to the fitness of EC958 in
gastrointestinal colonisation. Notably, although the backbone of
EC958 is most similar to E. coli SE15 (including ROD1–3 and GI-
thrW), the latter strain lacks GI-pheV, GI-selC, much of GI-leuX and
six of the prophage identified in EC958.
Sequence analysis of the type 1 fimbriae encoding genes
in E. coli EC958
Type 1 fimbriae, encoded by the fim genes, are a major
virulence factor of UPEC; they mediate binding to a-D-
mannosylated proteins such as uroplakins, which are abundant
in the uroepithelial lining of the bladder [25], invasion of
superficial bladder epithelial cells [26] and the formation of
intracellular bacterial communities (IBCs) [27]. Investigation of
the fim operon sequence in EC958 revealed a 1,895 bp insertion in
the fimB gene, which encodes the FimB recombinase that switches
on the expression of type 1 fimbriae. The insertion in the coding
sequence of fimB is a single unit containing two coding sequences
(CDS) and 23 bp terminal imperfect inverted repeats, flanked by
5 bp direct repeats (Figure 2). One CDS encodes a transposase
with sequence similarity to transposases of the ISL3 family of
insertion sequence elements. The second CDS encodes a
conserved hypothetical protein with no sequence similarity to
Figure 1. Genomic map of ST131 E. coli EC958. The inner circle represents the reference sequence, E. coli EC958, with scaffolds of the draft
assembly displayed as alternating blue or red color in the inner-most ring. Outer rings show shared identity (according to BLASTn) with individual
UPEC genomes and various other E. coli genomes. BLASTn matches between 80% and 100% nucleotide identity are colored from lightest to darkest
shade, respectively, according to the graduated scale on the right of the circular BLAST image. Matches with less than 80% identity, or E. coli EC958
regions with no BLAST matches, appear as blank spaces in each ring. Rings indicate BLAST identity, from inside to out, between EC958 and: (1–5)
individual UPEC genomes CFT073, 536, UTI89, IAI39, UMN026 (light to dark blue); (6) pooled ExPEC genomes: APEC O1, IHE3034, S88 (purple); (7)
pooled EHEC/EPEC genomes: EC4115, Sakai, EDL933, E2348 (pink); (8) pooled EAEC/AIEC/ETEC genomes: 55989, O42, LF82, E24377A (yellow); (9)
environmental E. coli genome: SMS_3_5 (lime green); (10) pooled commensal E. coli genomes: IAI1, SE11, SE15, HS, 8739, ED1a (teal); pooled E. coli
K12 genomes: MG1655, W3110, DH10B (green). Black labels indicate regions that are known to be variable in E. coli genomes. Blue labels and arcs
indicate RODs that appear to be prophage regions; red labels and arcs indicate known genomic islands (GI-pheV, GI-selC, GI-thrW, and GI-leuX) or
potential new genomic islands (ROD1–3). The image was prepared using Blast Ring Image Generator (http://sourceforge.net/projects/brig).
doi:10.1371/journal.pone.0026578.g001
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transposases or any conserved domains usually associated with
transposases.
None of the E. coli genomes analysed in Figure 1 contain an
insertion in the fimB gene. Interestingly, we found that the
insertion in EC958 fimB is in exactly the same location and almost
identical in sequence (with the exception of a 3 bp deletion in one
direct repeat and a single SNP) to the fimB insertion described in
the widely-used probiotic E. coli strain Nissle 1917 (Figure 2) [28].
To further investigate the prevalence of the EC958 fimB insertion
we examined our collection of 54 ST131 clinical isolates by PCR
and identified thirty two (59%) that contained an insertion of
similar size in fimB. Sequencing of the 59 and 39 ends of these PCR
products revealed that the insertion element among the ST131
strains examined was identical to that identified in the genome of
EC958.
Type 1 fimbriae expression is not a conserved trait
among ST131 E. coli
We anticipated that inactivation of the FimB recombinase in
EC958 would affect the strain’s ability to switch on expression of
type 1 fimbriae. To test this tenet we used the yeast cell
agglutination assay, a standard method for monitoring the
production of functional type 1 fimbriae. Overnight shaking
cultures of EC958 were negative for type 1 fimbriae expression. As
static aerated growth in liquid media strongly selects for expression
of type 1 fimbriae, we performed yeast cell agglutination assays
with EC958 following three rounds of static culture in LB broth.
Static growth resulted in functional expression of type 1 fimbriae
in EC958. A similar switching phenotype has been demonstrated
for type 1 fimbriae in E. coli strain Nissle 1917 [28]. As both strains
contain a near identical insertion in the fimB gene, it is tempting to
speculate that this distinct pattern of slow OFF-to-ON switching of
type 1 fimbriae results from the action of another recombinase that
can act on the fim switch and turn on type 1 fimbriae expression.
In the case of the E. coli K-12 reference strain MG1655, FimE -
the second tyrosine recombinase encoded in the fim operon - can
switch the fim promoter from the ‘off’ to the ‘on’ orientation in the
absence of FimB under aerobic static culture conditions [29]. In
the fimB-null Nissle 1917 strain, however, FimE is not responsible
for turning on expression of type 1 fimbriae under static growth
conditions, as a double fimB,fimE mutant is still able to switch on
expression of type 1 fimbriae under these conditions, suggesting
that an alternative recombinase mediates off-to-on switching [28].
Two such recombinases, ipuA and ipbA (also known as hbiF and
fimX) have previously been shown to catalyze off-to-on switching of
type 1 fimbriae expression in a fimBE-independent manner
[30,31,32]. The tyrosine recombinase-encoding ipbA gene is
prevalent among uropathogenic and commensal E. coli strains
and a copy of the ipbA gene is present in the E. coli EC958 genome.
E. coli EC958 also possesses an intact fimE gene encoded
downstream of fimB. Either of these two fimB homologs could
potentially mediate the observed switching in the absence of fimB.
To investigate type 1 fimbriae expression in the ST131 lineage
we performed yeast cell agglutination assays for the 54 E. coli
ST131 isolates in our collection following shaking and static
culture in LB broth. Thirty four of the strains (63%) were negative
for type 1 expression following shaking culture. Interestingly the
majority of these strains (26/34, 76.5%) had a disrupted fimB gene
due to a sequence insertion, similar to strain EC958. For the
ST131 isolates in our collection there was a significant association
between encoding a disrupted fimB gene and the lack of functional
type 1 fimbriae production (p=0.001, Chi-square test). When
cultured statically, 27 of the 34 negative strains (79%) became
positive for production of type 1 fimbriae, similar to strain EC958,
while 7 strains remained negative. Taken together, our screen for
type 1 fimbriae expression among ST131 isolates identified three
phenotypes: i) ‘fim-off’, representing strains unable to switch on
expression (7/54, 13%), ii) ‘fim-enriched’, representing strains that
Table 1. E. coli ST131 antibiotic resistance genes.
Gene Description pEC958 pEK4991 pC15-1a
blaTEM-1 b-Lactamase TEM-1 precursor + (13)2 + (1) + (8)
tet(A)
tet(R)
Tetracycline resistance protein, class A
Tetracycline resistance protein
+ (12)
+ (11)
+ (2)
+ (3)
+ (1)
+ (2)
aac69-Ib-cr
blaOXA-1
Aminoglycoside N(69)-acetyltransferase
b-Lactamase OXA-1 precursor
+ (10)
+ (9)
+ (4)
+ (5)
+ (4)
+ (3)
DcatB43 Chloramphenicol acetyltransferase + (8) + (6) + (5)
aac39-II Aminoglycoside N(39)-acetyltransferase II 2 2 + (6)
blaCTX-M-15 Extended spectrum b-lactamase CTX-M-15 + (7) + (7) + (7)
dhfrVII
aadA5
sulI
Dihydrofolate reductase type VII
Aminoglycoside-3-adenyltransferase
Dihydropteroate synthetase type I
+ (1)
+ (2)
+ (3)
+ (8)
+ (9)
+ (10)
2
2
2
mph(R)
mrx
mph(A)
Erythromycin resistance repressor protein
Erythromycin resistance regulator protein
Macrolide 2-phosphotransferase
+ (4)
+ (5)
+ (6)
+ (11)
+ (12)
+ (13)
2
2
2
ampC(CMY) AmpC b-Lactamase, CMY-type 24 2 2
1+/2 indicates presence/absence of indicated gene; Numbers in parentheses refer to order of genes in plasmid; horizontal lines indicate boundaries for antibiotic
resistance gene cassettes that are commonly separated by Insertion Sequence (IS) elements.
2Like in pEK499, the blaTEM-1 gene in pEC958 is found as part of a complex transposon, separated from the other antibiotic resistance genes by the replication region. In
pEC958, however, there is an additional ,24 kb region encoding conjugation genes between blaTEM-1 and the replication region.
3All three plasmids carry a catB4 gene truncated by an IS26 element at nucleotide position 442 (relative to pEK499 catB4). In addition, pC15-1a catB has been further
disrupted by the inversion of the aacA4/oxa-1 cassette.
4An ampC gene with 100% amino acid identity to CMY-23 (gb|ABD94117) was identified within a putative genomic island within the EC958 chromosome.
doi:10.1371/journal.pone.0026578.t001
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switch on expression following static growth (27/54, 50%), similar
to strain EC958 and iii) ‘fim-on’, representing strains that produce
type 1 fimbriae under all conditions tested (20/54, 37%). Two
strains were selected from each group (Table 3) and compared to
the genome-sequenced EC958 (‘fim-enriched’) strain for uroviru-
lence in vitro and in vivo.
Virulence properties of E. coli EC958 and ST131 E. coli
The selected E. coli ST131 strains were tested for virulence
phenotypes that are commonly associated with uropathogenesis.
Bacterial adhesion of six E. coli ST131 strains to host cells was
assessed using T24 human bladder epithelial cell monolayers.
After overnight static culture to enrich for type 1 fimbriae the ‘fim-
enriched’ strains (EC958 and S52) and the ‘fim-on’ strains (S15
and S19) were highly adherent to bladder epithelial cells, while the
‘fim-off’ strains (S1 and S27) bound significantly less (P,0.001,
Kruskal-Wallis; Figure 3A). The adherent strains were also able to
invade T24 bladder epithelial cells, while the intracellular loads of
the two ‘fim-off’ strains were significantly lower (P,0.001,
Kruskal-Wallis; Figure 3B).
Type 1 fimbriae expression in E. coli EC958 is required for
colonisation of the bladder, but not persistence in urine,
in a mouse infection model
Our finding that fimB is disrupted in strain EC958 and many of
the ST131 isolates in our collection, together with the effects of the
insertion on the production of type 1 fimbriae, prompted us to
investigate the ability of ST131 strains to colonise the mouse
Table 2. Major virulence factors of EC958 and other sequenced UPEC/ExPEC strains.
EC958 CFT073 UTI89 536 UMN026 IAI39 IHE3034 Source1
Adhesins
fimA-H2 + + + + + + + CFT073:c5393–5400
papA-G 2 + + + + + 2 CFT073:c3583–3592
focA-H 2 + + + 2 2 + CFT073:c1239–1245
afa + 2 2 2 2 2 2 gb|FM955461
curli + + + + + + + CFT073:c1299–1307
Autotransporters
agn433 +4 + +5 + + 2 +5 CFT073:c1273
upaG + + + + +4 2 +5 CFT073:c4424
upaH + +4 + + 2 2 + gb|ACX47353
sat +4 + 2 2 + +4 2 CFT073:c3619
picU +5 + 2 2 2 2 2 CFT073:c0350
Toxins
hlyA 2 + + + 2 2 2 CFT073:c3570
cnf1 2 2 + 2 2 2 2 UTI89:UTI89_C4921
Iron receptors
fepA + + + + + + + CFT073:c0669
iroN 2 + + + 2 2 + CFT073:c1250
iutA2 +4 + 2 2 + + 2 CFT073:c3623
ireA 2 + 2 2 2 2 2 CFT073:c5174
iha2 +4 + 2 2 + 2 2 CFT073:c3610
chuA + + + + + + + CFT073:c4308
hma + + + + 2 + + CFT073:c2482
fyuA2 + + + + + + + CFT073:c2436
Others
kpsM2 + + + +5 + + + CFT073:c3698
usp2 + +4 + + 2 2 + UTI89:UTI89_C0121
ompT2,6 + + + + + + + CFT073:c0652
malX2 + + + + + + + CFT073:c2013
1Strain name and unique locus tag for reference sequence used in BLASTn search of EC958 and complete UPEC genomes (accession number provided for queries not
found in complete genome sequences); + or 2 indicates presence or absence, respectively; unless otherwise indicated, genes share .90% nucleotide identity with
reference sequence and presence was confirmed using ACT comparison.
2Indicated gene found in 91–100% of O25b-ST131 E. coli isolates from two previous studies [6,7].
3CFT073, UMN026 and 536 have two agn43 alleles whereas UTI89, IHE3034 and EC958 each have only one; Although the EC958 agn43 allele is similar to both CFT073
alleles, the UTI89 and IHE3034 alleles are distinct with limited amino acid similarity throughout their central domains (data not shown).
4Truncated gene or putative pseudogene; in EC958 these are all caused by assembly breaks and may be bona fide full-length genes.
5Gene shares ,90% identity with reference sequence.
6There are two paralogous copies of ompT found in IHE3034; CFT073, UTI89, 536 and EC958 carry only a single copy corresponding to IHE3034 ECOK1_0575, whereas
UMN026 and IAI39 contain only a single copy corresponding to IHE3034 ECOK1_0571.
doi:10.1371/journal.pone.0026578.t002
Genomics and Virulence of ST131 E. coli
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26578
urinary tract. We used the mouse model of ascending UTI to test
the colonisation potential of EC958 where the inoculum was
cultured under shaking (low expression of type 1 fimbriae) or static
(high expression of type 1 fimbriae) conditions. EC958 failed to
colonise the mouse bladder after shaking culture, but upon
expression of type 1 fimbriae (static culture) bladder colonisation
increased dramatically by a significant 5.6 log median difference in
CFU/0.1 g tissue (p,0.001, Mann-Whitney) (Figure 4A). In
contrast, EC958 bacterial counts in urine were high following
both shaking and static culture (Figure 4B). To investigate the
importance of this finding further, we extended our in vivo study to
include two other ‘fim-enriched’ ST131 isolates (S47 and S52).
Similar to our results with EC958, bladder colonisation by S47
and S52 was significantly enhanced after static culture (p,0.05,
Mann-Whitney) (Figure 4A). In addition, both strains were
successfully recovered from mouse urine and the numbers were
not significantly different between shaking and static culture
conditions (Figure 4B). As a comparison, we also examined the
colonisation potential of two ‘fim-on’ (S15 and S19) and two ‘fim-
off’ (S1 and S27) ST131 isolates in vivo. The ‘fim-on’ strains were
able to colonise the mouse bladder and urine at levels comparable
to the ‘fim-enriched’ strains, while the ‘fim-off’ strains were
recovered in significantly lower numbers from mouse bladders and
urine (Figure 4C–D). The molecular mechanism that defines the
‘fim-off’ state, as well as the mechanism by which these strains can
colonize the human bladder and cause disease, remains unknown.
Taken together our results demonstrate that expression of type 1
fimbriae enhances bladder colonisation by ST131 strains with the
‘fim-enriched’ switching phenotype, but strong expression of type
1 fimbriae is not required for EC958 persistence in urine in vivo.
An E. coli EC958 fim mutant is attenuated for colonisation
of the mouse bladder
In order to dissect the contribution of type 1 fimbriae to E. coli
ST131 virulence we constructed an isogenic fimD knockout mutant
in EC958. To overcome the challenge of genetically manipulating
the multidrug resistant EC958 strain, we modified the l-Red
mediated homologous recombination method [33] by cloning the
gentamicin resistance gene into a vector containing the l-Red
recombinase. Insertional inactivation of fimD was performed using
the chloramphenicol resistance cassette from pKD3, since the
native catB4 gene encoded in pEC958 is truncated by an IS26
element (see Table 2). The isogenic EC958fimD mutant lacked
surface expression of type 1 fimbriae following either shaking or
static culture and was unable to adhere in significant numbers to
T24 bladder epithelial cells (p,0.001, Figure 5A). The ability of
EC958fimD to colonise the mouse bladder was compared to wild-
type EC958 in a mouse model of UTI. EC958fimD was recovered
from the mouse bladder in significantly reduced numbers
compared to the wild-type EC958 strain (p,0.05, Mann-Whitney)
(Figure 5B). The same result was also observed in 1:1 mixed
infection experiments, where EC958 significantly outcompeted
Figure 2. BLASTn comparison of the type 1 fimbriae operon (blue) from E. coli strains CFT073, EC958 and a genomic fragment from
Escherichia coli strain Nissle, a natural fimB null strain [28], showing an insertion within fimB. The red shading indicates high nucleotide
identity between the sequences (99–100%). In EC958 the fimB gene (brown) has been disrupted by the insertion of an ISL3-like transposase gene
(light pink) and a gene of unknown function (orange). The inserted sequence, and the point of insertion is nearly identical to that observed in E. coli
Nissle fimB (GenBank:AF188737).
doi:10.1371/journal.pone.0026578.g002
Table 3. UK ST131 strains selected for in vitro and in vivo virulence studies.
Strain ID Year of isolation fimB insertion
aYA
(shaking)
bYA
(static)
Type 1 fimbriae
phenotype
S15
S19
2009
2009
2
2
+
+
+
+
fim-on
fim-on
S1
S27
2007
2009
+
2
2
2
2
2
fim-off
fim-off
EC958
S47
S52
2005
2005
2005
+
+
+
2
2
2
+
+
+
fim-enriched
fim-enriched
fim-enriched
aYeast agglutination (YA) following shaking growth.
bYeast agglutination (YA) following 3 rounds of static growth.
doi:10.1371/journal.pone.0026578.t003
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EC958fimD for bladder colonisation (Log10 competitive index
[EC958fimD/EC958] =23.426; p=0.003, Wilcoxon Signed
Rank). Our findings using the EC958fimD knockout strain
demonstrate a role for type 1 fimbriae in bacterial adhesion and
bladder colonisation. Taken together our results demonstrate that
the genome-sequenced ST131 strain EC958 has a distinct set of
virulence phenotypes and in vivo colonisation pattern that are also
shared with other ‘fim-enriched’ strains from the UK ST131
isolate collection.
The insertion in fimB in EC958 is also present in E. coli
isolates of the ST131 lineage from Australia
We extended our study to a collection of twenty one ST131
isolates from UTI patients presenting to two hospitals in Australia
from 2007–2010. We detected the same insertion in fimB in 71%
of these isolates. The sequence was highly identical to that present
in EC958 and type 1 fimbriae expression in these isolates displayed
the same ‘fim-enriched’ phenotype observed with EC958 following
static culture conditions. Most importantly, a similar pattern of in
vivo bladder colonisation to that of EC958 was observed with B36,
one of the ‘fim-enriched’ isolates from Australia that was tested in
the mouse UTI model (Figure 4E). These results provide further
support for a role of type 1 fimbriae in bladder colonisation by
isolates belonging to the ST131 lineage.
Conclusions
The rapid and widespread dissemination of multiply antibiotic
resistant UPEC strains from the ST131 lineage in hospitals and
the community represents a serious threat to healthcare resources
worldwide. Alarmingly, ST131 strains that have acquired a new
type of metallo-b-lactamase, NDM-1, conferring resistance to
carbapenems - often our last line of defence against multiresistant
E. coli infections - have been recently reported [34]. The
identification of NDM-1 producing ST131 strains highlights the
importance of understanding the virulence mechanisms employed
by this highly successful E. coli clone. This study provides the first
genomic insight into this emerging group of E. coli pathogens and
reveals the extent of its virulence potential. Even though the strain
is particularly well equipped to resist the action of many
antibiotics, the genome sequence of E. coli ST131 strain EC958
contains an extensive array of UPEC-associated virulence factors,
genomic islands and prophage regions that distinguish it from
other E. coli pathotypes. It has previously been suggested that
carriage of the genes required for both pronounced virulence and
high level antibiotic resistance results in strains that are
metabolically disadvantaged and not fit for persistence/infection.
This is clearly not the case for ST131 strains. E. coli EC958 carries
a CTX-M15 plasmid which is a cointegrate of pEK499 and pC15-
1a with resistance to eight antibiotic classes. Sequencing the
genome of EC958 facilitated the identification of type 1 fimbriae
as a key virulence factor in its pathogenicity. The transposase
insertion identified in the fimB recombinase in the genome of
EC958 was also found in multiple independently isolated ST131
strains from opposite sides of the globe, suggesting that it occurred
early in the divergence of the ST131 lineage. Using in vitro
functional assays we demonstrated that this insertion results in
reduced frequency of switching on type 1 fimbriae expression and
implicates the activity of a second tyrosine recombinase in this
process. Two candidate recombinases have been identified in the
genome of EC958 and studies investigating their role in switching
on type 1 fimbriae expression are under way. Using a mouse
model of ascending UTI we established the role of type 1 fimbriae
in EC958 virulence in vivo. Sequencing more E. coli ST131 clinical
isolates from geographically diverse collections will add to our
understanding of the genetic basis for uropathogenesis and the
global dissemination of strains belonging to the E. coli ST131
clonal group.
Materials and Methods
Ethical approval
This study was carried out in strict accordance with the
recommendations in the Animal Care and Protection Act
(Queensland, 2002) and the Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes (7th edition,
2004). Approval for mouse infection studies was obtained from the
University of Queensland Animal Ethics Committee (SCMB/
471/09/NHMRC (NF)).
Strains
Clinical UTI isolates were obtained from urine samples received
by microbiology laboratories at hospitals in Manchester and
Figure 3. E. coli EC958 and ST131 strain adhesion (A) and invasion (B) of human bladder epithelial cells. Triplicate T24 cell monolayers
were infected with ST131 strains EC958, and S52 (‘fim-enriched’, white), S15 and S19 (‘fim-on’, light grey), S1 and S27 (‘fim-off’, dark grey) at a
multiplicity of infection (MOI) of 10 and incubated at 37uC, 5% CO2 for 1 hour. Adherent and intracellular bacteria were enumerated by plating on LB
agar. Boxplots summarize CFU/ml data of three experimental repeats.
doi:10.1371/journal.pone.0026578.g003
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Figure 4. Mouse urinary tract colonisation by E. coli EC958 and ST131 strains. A minimum of eight C57BL/6 mice were transurethrally
inoculated with ,56108 CFU of each ST131 strain. After 18 h urine and bladder homogenate samples were plated on LB agar in triplicate for
determination of bacterial loads. Data are presented as log CFU per ml of urine or 0.1 g of tissue. Bladder (A) and urine (B) bacterial loads of ‘fim-
enriched’ ST131 strains EC958, S47 and S52 determined following shaking or static growth of the culture inoculum. Bladder (C) and urine (D) bacterial
loads of S15, S19 (‘fim-on’) and S1, S27 (‘fim-off’) ST131 strains. (E) Bladder and urine bacterial loads of B36 following shaking and static growth. B36 is
an ST131 ‘fim-enriched’ strain from our Australian collection. Equality of group medians was tested using the Mann-Whitney nonparametric test.
Shown P values,0.05 are considered significant.
doi:10.1371/journal.pone.0026578.g004
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Preston, Northwest England and Brisbane, Australia. E. coli
isolates were collected as part of routine methods for the diagnosis
of UTI. All samples were de-identified; individual informed
consent was not required.
All E. coli strains used in this study were routinely cultured at
37uC on solid or in liquid Luria Broth (LB) medium. All ST131
isolates met the selection criteria of being recovered from non-
duplicate urine cultures of patients presenting with UTI, where
CFU counts were .16105 ml21 with the presence of elevated
levels of white cells.
Molecular methods
The isolates examined in the current study were subjected to
multilocus sequence typing (MLST) as previously described
[15,35]. Some of the isolates in the current collection were
included in these previous studies. Chromosomal DNA purifica-
tion, PCR and DNA sequencing of PCR products was performed
as previously described [36]. PCR screening and sequencing of the
fimB insertion was performed using oligonucleotides fimB-IS_F 59-
TCCTGACCCATAGTGAAATCG-39 and fimB-IS_R 59-
GCTCTATCCCAGATGCCGTA-39. For insertional inactiva-
tion of the fimD gene in EC958, the chloramphenicol resistance
cassette was amplified from pKD3 using primers 2141 (59-
cgcaactcgccagtatggggctgaatatggcttctgtcgccggtatgaatctgctggcggat-
gatgcctgtgggaattagccatggtcc) and 2142 (59-gtatccagcgc-
cactctgttttcccgatattcggtggcataaggcagcacggcataaccgcgccagtcgggtg-
taggctggagctgcttc), containing 50 nucleotide flanking regions
complementary to the beginning and end of fimD. The knock-
out PCR product was introduced by electroporation into EC958
transformed with a gentamicin resistant plasmid carrying the l-
Red recombinase. Insertional inactivation of fimD was performed
as previously described [33] and the constructed mutant was
confirmed by sequencing of the insertion sites.
Genome sequencing and annotation of E. coli EC958
Genomic DNA of E. coli EC958 was sequenced using a 454 GS-
FLX by the Centre for Genomic Research, University of
Liverpool. The 454 GS Assembler 2.5.3 software was used to
assemble 826269 sequence reads into 240 contigs greater than
200 bp in length with an average depth of 29-fold coverage.
Approximately half of the reads were mate-paired (with an average
insert size of 3189) enabling 155 contigs to be linked into 16
scaffolds. Chromosomal scaffolds ranged in size from 2,462 bp to
1,197,002 bp with 99% of the genome assembled into 9 large
scaffolds greater than 100 kb in length. After manual validation of
the assembly using consed [37], scaffolds were ordered according
to the genome of UPEC UTI89 [19] and annotated using
SUGAR, an in-house draft genome annotation pipeline (Szubert
and Beatson, unpublished). The assembly also included 175
unscaffolded contigs (.200 bp) corresponding mostly to repetitive
elements such as insertion sequences (IS) and rRNA operons.
Comparison and visualization of E. coli genomes was carried out
using BLAST [38], ACT [39], Easyfig [40] and BRIG [41]. The
EC958 draft scaffolds have been deposited in the EMBL WGS
database (EMBL Accession CAFL01000001 to CAFL01000240).
The features of the noted regions from the EC958 genome
(Figure 1) are provided in Table S1. The sequence of each of these
regions is provided in Dataset S1.
Yeast cell agglutination assay
Expression of functional type 1 fimbriae on the surface of
ST131 E. coli strains was determined by agglutination of yeast cells
(Saccharomyces cerevisiae). Clinical isolates were plated onto LB agar.
Five single colonies of each strain were pooled, inoculated into
3 ml LB and incubated shaking or statically for 24 h. Static
cultures were then passaged statically in two further rounds of
incubation. Agglutination was performed by mixing a suspension
of bacterial cells with an equal volume of yeast cells (diluted to 5%
in phosphate buffered saline [PBS]) on a glass slide and the visual
observation of bacterial-yeast aggregation. UPEC strains UTI89
and 83972 were used as positive and negative controls in all assays.
ST131 strains that failed to produce visible agglutination of yeast
cells after 3 minutes were scored negative.
Epithelial cell adhesion and invasion assay
The ability of ST131 strains to adhere to human bladder
epithelial cells was tested as previously described [42]. T24 bladder
epithelial cells (ATCC HTB-4) were maintained in McCoy’s 5A
Figure 5. Virulence of E. coli EC958 and isogenic fimD knockout mutant. (A) Adhesion of EC958 (grey) and EC958fimD (white) to T24 human
bladder epithelial cells following shaking or static culture. Boxplots summarize CFU/ml data of three experimental repeats. (B) Bacterial loads in
mouse bladders recovered 18 hours post- infection with EC958 and EC958fimD. Data are presented for each mouse as log10 (CFU/0.1 g tissue).
Horizontal bars show group medians.
doi:10.1371/journal.pone.0026578.g005
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medium (modified) (Invitrogen) supplemented with 10% heat-
inactivated fetal calf serum (Invitrogen). Confluent T24 cell
monolayers were infected with ST131 strains at a multiplicity of
infection (MOI) of 1:10 and incubated at 37uC, 5% CO2 for
1 hour. Non-adherent bacteria were removed by 5 washes with
PBS. T24 cell lysates were serially diluted and plated onto LB agar
plates to enumerate adherent bacteria. Enumeration of intracel-
lular bacterial loads was performed in a similar way, following
exclusion of extracellular bacteria by gentamicin treatment
(200 mg ml21) for 1 hour.
Mouse model of UTI
The C57BL/6 mouse model of ascending UTI was employed as
previously described [36]. Briefly, female C57BL/6 mice (8–10
weeks) were transurethrally inoculated with ,56108 CFU using a
1 ml tuberculin syringe attached to a sterile catheter. After
18 hours, urine and homogenated bladder samples were processed
for bacterial loads by viable CFU counts performed in triplicate.
Data are presented as log CFU per ml of urine or 0.1 g of tissue
for each mouse. A minimum of 8 mice was included in each strain
group. Equality of group medians was tested using the Mann-
Whitney nonparametric test.
Supporting Information
Table S1 Features of the specific regions from the
EC958 genome noted in Figure 1.
(XLSX)
Dataset S1 Sequence of each of the specific regions
from the EC958 genome noted in Table S1.
(TXT)
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